Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of Veterinary Research. 2015; 70 (1): 1-5
in Persian | IMEMR | ID: emr-177059

ABSTRACT

Background: Babesiosis and Thosis are parasitic tick-borne diseases that cause a lot of economic loss in livestock Industry


Objectives: The purpose of the present study was to detect Babesia and Theileria infection in goats and and vector ticks in goats in Mashhad


Methods: One hundred blood samples of goats and 246 ticks were collected from some suspected flocks with history of piroplasmosis. The samples were transported to laboratory under cold condition. Blood smears were prepared and stained by Geimsa method and examined with a light microscope at ×1000 magnitude. The collected ticks were separated into tick pools of five according to their species and sex. The blood, salivary gland and ovaries of tick samples were examined using specific primers of Babesia.spp and Theileria.spp by semi nested-PCR


Results: Piroplasm bodies were not observed in any blood samples of goat in Mashhad. In a total of 246 collected ticks, seven species were identified as follows: R. turanicus 127[51.6%], D. marginatus 67 [27.2%], Hy. marginatum 44 [17.9%], R. sangunincus 4[1.6%], Hy. anatolicum 2[0.8%], Hy. asiaticum 1[0.4%] and Heam. sulcata 1[0.4%]. Dominant tick species of goats in Mashhad suburb were R. turanicus and D. marginatus. The results of PCR showed that none of the blood samples were infected with Babesia spp. and Theileria spp. Also, Theileria infectoin was detected in a sample salivary glands of Hy. marginatum


Conclusions: Based on microscopic and molecular results, no Theileria spp. and Babesia spp. infection were detected in goats. R.turanicus was the dominat tick species and Theileria spp. infection was detected in one sample of Hy.marginatum

2.
Journal of Zanjan University of Medical Sciences and Health Services. 2011; 18 (73): 58-66
in Persian | IMEMR | ID: emr-110830

ABSTRACT

Anemia is present in 60-80% of hemodialysis patients. Recombinant erythropoietin is the treatment of choice for anemia in these patients, but it is expensive. Many researchers have shown the effect of carnitine on anemia. Therefore, this work was designed to evaluate the influence of intravenous carnitine on hemoglobin and hematocrit levels in chronic renal disease patients who were under hemodialysis. This study was accomplished on 29 patients who were under hemodilysis for at least one year and did not have other reasons for their anemia. Using balance block randomization method the patients divided in to two groups: placebo group [n=15] and case group [n=14]. After each dialysis session [3 times a week for 3 months] the case group was injected 1 gr intravenous carnitine while the placebo group received 1 gr distilled water. There was no significant difference between the two groups regarding sex and age. The average amount of hemoglobin and hematocrit was equal in two groups before the intervention. But, finally after the intervention the amount of hemoglobin and hematocrit significantly increased in the case group [P=0.001 and P=0.003 respectively]. Findings of this study revealed that carnitine increases the amount of hemoglobin and hematocrit in hemodialysis patients and improves their anemia. However, further studies with more patients are recommended


Subject(s)
Humans , Male , Female , Hemoglobins/drug effects , Hematocrit/drug effects , Kidney Failure, Chronic , Renal Dialysis , Injections, Intravenous , Anemia/drug therapy , Random Allocation , Placebos
SELECTION OF CITATIONS
SEARCH DETAIL